Menu

HAYAT PHARMACEUTICAL INDUSTRIES CO. Financial

Trading Information in the Regular Market

2021 2020 2019
Par Value/Share (JD) 1.00 1.00 1.00
Closing Price (JD) 3.79 2.42 1.96
Value Traded (JD) 12,523,483 1,290,716 1,005,003
No. of Shares Traded 3,476,520 608,214 535,272
No. of Transactions 1,111 1,289 714
No. of Subscribed Shares 9,500,000 9,500,000 9,500,000
Market Capitalization (JD) 36,005,000 22,990,000 18,620,000
Fiscal Year Ended 31/12/2021 31/12/2020 31/12/2019

Assets (JD)

2021 2020 2019
Cash on Hand & at Banks 7,194,796 5,859,073 3,161,991
Notes Receivable 0 0 0
Post Dated Cheques 1,691,369 3,297,078 2,197,144
Short Term Investments 0 0 0
Inventory 2,913,025 2,385,173 2,627,912
Spare Parts 329,232 408,637 167,193
Total Current Assets 18,460,575 19,257,913 15,003,717
Long Term Investments 10 10 10
Fixed Assets, Net 11,962,621 10,830,862 4,824,998
Lands 1,879,381 1,879,381 1,879,381
Projects in Progress 200,633 645,959 6,357,322
Total Fixed Assets 14,042,635 13,356,202 13,061,701
Other Assets 0 0 0
Total Assets 32,503,220 32,614,125 28,065,428

Liabilities (JD)

2021 2020 2019
Credit Banks 0 0 2,439
Short Term Loans 0 0 0
Current Part of Long Term Loans 734,136 734,136 400,800
Total Current Liabilities 3,471,805 4,701,852 3,087,252
Long Term Loans & Notes Payable 815,238 1,438,316 1,064,800
Corporate Bonds 0 0 0
Other Liabilities 0 0 0
Total Liabilities 4,287,043 6,140,168 4,152,052

Shareholders Equity (JD)

2021 2020 2019
Authorized Capital 9,500,000 9,500,000 9,500,000
Subscribed Capital 9,500,000 9,500,000 9,500,000
Paid in Capital 9,500,000 9,500,000 9,500,000
Compulsory Reserves 3,456,438 3,023,304 2,615,308
Voluntary Reserve 3,234,231 2,801,097 2,393,101
Other Reserves 0 0 0
Issuance Premium 0 0 0
Issuance Discount 0 0 0
Treasury Stocks 0 0 0
Cash Dividends 2,375,000 1,900,000 950,000
Stock Dividends 0 0 0
Accumulated Change in Fair Value 0 0 0
Retained Earnings 9,650,508 9,249,556 8,454,967
Total Shareholders Equity 28,216,177 26,473,957 23,913,376
Non-controlling Interest 0 0 0
Total Liabilities & Shareholders Equity 32,503,220 32,614,125 28,065,428

Income Statement (JD)

2021 2020 2019
Operating Revenues 16,583,721 16,580,369 15,644,027
Operating Expenses 5,354,483 5,197,440 5,618,894
Gross Profit 11,229,238 11,382,929 10,025,133
General and Administrative Expenses 1,603,254 1,845,240 2,094,154
Selling and Distribution Expenses 4,614,951 4,835,813 3,804,436
Depreciation (Period) 899,417 479,054 464,287
Other Operating Expenses 650,230 606,421 373,285
Net Operating Income 4,360,803 4,095,455 3,753,258
Other Revenues 96,272 115,362 151,763
Other Expenses 0 0 0
Income Before Interest & Tax 4,457,075 4,210,817 3,905,021
Interest Expenses 90,731 107,246 120,299
Net Income Before Tax 4,366,344 4,103,571 3,784,722
Income Tax (Period) 689,124 569,379 417,846
Income Tax (Previous Years) 0 0 0
Universities and Research Train Fees 0 0 0
Board of Directors Remuniration 35,000 23,611 35,000
Net Income 3,642,220 3,510,581 3,331,876
Non-controlling Interest 0 0 0
Net Income Pertains to Shareholders 3,642,220 3,510,581 3,331,876

Cash Flow (JD)

2021 2020 2019
Cash Balance (Beginning) 5,859,073 3,161,991 4,468,746
Net Cash Flow from (Used in) Operating Activities 5,535,382 3,823,470 2,685,108
Net Cash Flow from (Used in) Investing Activities -1,585,850 -773,555 -1,487,882
Net Cash Flow from (Used in) Financing Activities -2,613,809 -352,833 -2,503,981
Cash Balance (Ending) 7,194,796 5,859,073 3,161,991

Financial Ratios

2021 2020 2019
Turnover Ratio % 36.595 6.402 5.634
Earning Per Share (JD) 0.383 0.370 0.351
Dividend Per Share (JD) 0.250 0.200 0.100
Book Value Per Share (JD) 2.970 2.787 2.517
Price Earnings Ratio (Times) 9.886 6.549 5.588
Dividend Yield % 6.596 8.265 5.102
Dividend Per Share to Earning Per Share % 65.208 54.122 28.513
Price to Book Value (Times) 1.276 0.868 0.779
Gross Margin % 67.712 68.653 64.083
Margin Before Interest and Tax % 26.876 25.396 24.962
Profit Margin % 21.963 21.173 21.298
Return On Assets % 11.206 10.764 11.872
Return On Equity % 12.908 13.261 13.933
Debt Ratio % 13.190 18.827 14.794
Equity Ratio % 86.810 81.173 85.206
Interest Coverage Ratio (Times) 49.124 39.263 32.461
Total Assets Turnover (Times) 0.510 0.508 0.557
Fixed Assets Turnover (Times) 1.181 1.241 1.198
Working Capital Turnover (Times) 1.106 1.139 1.313
Current Ratio (Times) 5.317 4.096 4.860
Working Capital (JD) 14,988,770.000 14,556,061.000 11,916,465.000